Interleukin-13 Antagonists [MoA] - N0000193986

Pharmacologic Class Information

Pharmacologic Code N0000193986
Pharmacologic Name Interleukin-13 Antagonists
Pharmacologic Uses
  • interleukin-13 antagonist
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Interleukin-13 Antagonists

The table contains 1 products whose active ingredient are classified under the same pharmacologic class Interleukin-13 Antagonists [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
50222-346Adbry Non-Proprietary Name: Tralokinumab-ldrmInjection, SolutionSubcutaneousLeo Pharma Inc.ACTIVE